Cough syrup crisis: Tamil Nadu suspends 2 drug inspectors, moves to close pharma co
- byDoctor News Daily Team
- 11 October, 2025
- 0 Comments
- 0 Mins

Chennai: Two senior drug inspectors have been suspended for their inaction in the deadly cough syrup adulteration case that has claimed multiple lives, Tamil Nadu Health Minister Ma Subramanian said. The inspectors were served notice for failing to inspect the Sresen Pharma manufacturing facility for two years. In light of this, they were suspended from their positions. As per PTI, the minister also confirmed that steps will be taken to permanently shut down the pharma company whose product allegedly claimed many lives. "Tamil Nadu was the first to confirm the adulteration in the cough syrup (Coldrif) and we immediately informed the Union Health Ministry, Madhya Pradesh, Odisha, and even Puducherry about the health hazard of consuming the cough syrup," Subramanian told reporters here when his attention was drawn to the arrest of Sresen Pharma company owner G Ranganathan, today. Immediately, the state government issued "stop production" order on October 3 and temporarily revoked the company’s manufacturing licence. Criminal action was initiated on Ranganathan on October 7, and he was arrested past midnight on October 8, he said. Read also:TN based cough syrup pharma owner arrested in Chennai "Based on a detailed investigation, which is underway, steps will be taken to permanently close down the pharma company. A decision will be taken in three days’ time," the minister assured.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Mumbai's GT Hospital doctor injured after ceiling...
- 20 October, 2025
Rajasthan HC Quashes Ban on New B.Pharm Colleges,...
- 20 October, 2025
Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufactu...
- 20 October, 2025
CDSCO Panel Rejects Pure and Cure's Empagliflozin-...
- 20 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!